Article Details
Retrieved on: 2022-03-01 05:32:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
VentiRx Pharmaceuticals, Inc., a privately held biopharmaceutical company dedicated to the development of novel Toll-like receptor 8 (TLR8) agonists ...
Article found on: www.lifescienceleader.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here